Biotechnology News

September 9, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Trevi Therapeutics Selected to Exhibit Poster at 2014 Annual Meeting of the American College of Clinical Pharmacology

September 9, 2014

ST. LOUIS--(BUSINESS WIRE)--Euclises Pharmaceuticals, Inc., a biotechnology company developing novel COX-2 inhibitors for the treatment of cancer, today announced closing a $1.3 million Series A financing.

September 9, 2014

PERKASIE, Pa.--(BUSINESS WIRE)--Peter Gabriele and Jeremy Harris, Ph.D., will present “Anatomy of a Next-Generation Bioresorbable Coating for Medical Devices” during a live webinar Tuesday, September 23 at 11:00 am (ET).

September 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana Therapeutics has announced the USPTO granted patents that strengthen protections for Mersana's internal pipeline of Fleximer antibody-drug conjugates, as well as partnered programs.

September 9, 2014

MEQUON, Wis.--(BUSINESS WIRE)--ENDECE will present new, pre-clinical data for its lead compound, NDC-1308, inducing remyelination in vivo in animal model of demyelination at a poster session at the 2014 ACTRIMS/ECTRIMS meeting.

September 9, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Aphios awarded SBIR grant from NCCAM, NIH to design and develop instrumentation for its green drug discovery technology that improves the discovery rate of natural therapeutics and QOL medicines.

September 9, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the initial purchasers of the previously announced offering of the Company’s 2.50% Convertible Senior Notes due 2021 (the “Notes”) in a private placement...

September 9, 2014

OSLO, Norway--(BUSINESS WIRE)--Serodus has succesfully completed a Phase IIa clinical trial for its lead candidate drug SER100 in patients with systolic hypertension

September 9, 2014

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos”), a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug delivery technologies as well as a late-stage pipeline of innovative...

September 9, 2014

--(BUSINESS WIRE)--CKR Global, Canada’s leading risk mitigation company, combats 5 myths about Canadian companies' vulnerability to RCMP scrutiny and enforcement of the Corruption of Foreign Public Officials Act.

September 9, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides CEO Dr. Seymour to present the Company's programs with particular reference to the current Ebola outbreak at the Rodman & Renshaw Conference in New York City today afternoon.

September 9, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to a Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm. Co.

September 9, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today it has committed to invest $125 million in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) through senior secured convertible notes. The financing is expected to be funded before...

September 9, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical to Present Data at ESMO 2014 Congress

September 9, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to...

September 9, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

September 9, 2014

LEIDEN, Netherlands--(BUSINESS WIRE)--Anders Harfstrand Joins to-BBB as Chief Executive Officer

September 9, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside UK, US and Canada A pre-specified subgroup analysis from the two replicate Phase III INPULSIS™ trials, presented today at the European Respiratory Society International Congress (ERS), showed...

September 9, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutial AB (STO:NVP), a leading mitochondrial medicine company, has signed an exclusive global outlicensing agreement with the US biotechnology company OnCore BioPharma, Inc. related to...

September 9, 2014

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today...

September 8, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26, 2014 at 2:00 p.m. (EDT) in New York. The presentation will be webcast...

September 8, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will provide an overview of the company at the Morgan Stanley...

September 8, 2014

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc., a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, announced today that it has raised $40 million in private funding from a number of blue chip...

September 8, 2014

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The seventh annual BioPharm America™ international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place.

September 8, 2014

ATLANTA--(BUSINESS WIRE)--September is peripheral artery disease awareness month. PAD costs more than other major chronic diseases. Costs reflect PAD events plus cardiovascular events, diabetic foot ulcers and amputations.

September 8, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has signed a contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to...

September 8, 2014

LOS ANGELES--(BUSINESS WIRE)--Trifecta Clinical, a leading global provider of online clinical investigator training, is excited to announce the launch of Voices in Life Sciences (VLS) at the 2014 Disruptive Innovations in Boston. “Last year at...

September 8, 2014

PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that the Company has received approval from Brazilian National Health Surveillance Agency (ANVISA)...

September 8, 2014

BELMONT, Calif.--(BUSINESS WIRE)--LakePharma, a leading protein engineering contract research organization, is hosting its second annual Antibody Engineering Symposium this October 9th & 10th. The 2014 Symposium will be held at the South San...

September 8, 2014

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (Paris:IMPL), a medical technology company specializing in vertebral and knee-surgery implants, today announces the...

September 8, 2014

--(BUSINESS WIRE)--BIO and Biominas Brasil cohost the BIO Latin America Conference, the industry’s premier event for building innovation and collaboration in Latin America’s fast-growing biotechnology sector.

September 8, 2014

WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest Inc. today announced the appointment of Robert Hoyt as an independent director of the firm, effective immediately. Mr. Hoyt’s appointment expands the Board to six directors. “Bob’s enormous success...

September 8, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--Miles Orchinik, PhD, the School of Life Sciences at Arizona State University, named the 2014 Michael A. Cusanovich Arizona Bioscience Educator of the Year by AZBio

September 8, 2014

DURHAM, N.C.--(BUSINESS WIRE)--Novan Therapeutics, a clinical-stage biotech company focused on advancing nitric oxide therapies, announced today that Novan’s nitric oxide drug candidate SB206 was shown to inhibit papilloma growth in a preclinical...

September 8, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, announced today the launch of its Dyneema Purity® Radiopaque fiber, the only radiopaque ultra-high-molecular-weight-polyethylene (UHMWPE...

September 8, 2014

GRENOBLE, France--(BUSINESS WIRE)--Prof. Alim-Louis Benabid, chairman of the board of the French bio-medical research center Clinatec and member of the French Académie des Sciences, has been named co-winner of the prestigious 2014 Lasker~DeBakey...

September 8, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--September is Blood Cancer Awareness Month, and the MPN Coalition, a group of seven patient organizations, has designated September 11, 2014, as MPN Awareness Day. This day recognizes the approximately 300,000...

September 8, 2014

BOURNEMOUTH, England--(BUSINESS WIRE)--Solentim is pleased to announce the purchase of its Cell Metric™ CLD system for monoclonality verification by Horizon Discovery Group plc, which will use it as part of internal R&D projects.

September 8, 2014

SAN ANTONIO & COLUMBIA, Md.--(BUSINESS WIRE)--MedStar Health to Deploy AirStrip ONE for Labor and Delivery

September 8, 2014

DALLAS--(BUSINESS WIRE)--Perkins Healthcare Technologies is pleased to announce the selection of its Patient Observation & Fall Management Solution to be showcased at the 2014 Novation Innovative Technology Expo. The Expo will be held on...

September 8, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness announced positive results from the Company’s 42-week Functional Ambulation: Standard Treatment vs. Electrical Stimulation Therapy (FASTEST) trial of the Bioness L300® Foot Drop System.

September 8, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies, announced today that the US Food and Drug Administration (FDA) has...

September 8, 2014

BOSTON--(BUSINESS WIRE)--Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014

September 8, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present at Annual Meeting of the Association for Vascular Access (AVA)

September 8, 2014

MUNICH--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from the AMBITION study (a randomized, double-blind, multicenter study of first-line combination therapy with AMBrIsentan and Tadalafil in patients with...

September 8, 2014

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Edge Therapeutics today announced that it has obtained up to $10 million in venture debt financing from Hercules Technology Growth Capital, Inc. to support the continued development of EG-1962.

September 8, 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--LabCorp/ARCA biopharma joint personalized medicine poster selected for presentation at the 18th Annual Scientific Meeting of the Heart Failure Society of America

September 8, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that its multiple sclerosis pipeline, which includes a new generation of investigational treatments in early development, will be featured...

September 8, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment Conference